Yue Xu1, Aaron W James, Michael T Longaker. 1. Stanford, Calif. From the Hagey Pediatric Regenerative Research Laboratory and the Department of Surgery, Plastic and Reconstructive Surgery Division, Stanford University School of Medicine.
Abstract
BACKGROUND: Evidence from animal studies has associated transforming growth factor (TGF)-beta signaling with both normal and premature cranial suture fusion. However, the mechanisms whereby this pleiotropic cytokine mediates suture fusion remain uncertain. The authors established cultures of suture-derived mesenchymal cells from normally fusing (posterofrontal) and patent (sagittal) sutures and examined the in vitro effects of TGF-beta1 on these distinct cell populations. METHODS: Skulls were harvested from 80 5-day-old mice. Posterofrontal and sagittal sutures were dissected, and cultures of suture-derived mesenchymal cells were established. The mitogenic, osteogenic, and chondrogenic effects of recombinant TGF-beta1 were then assessed on posterofrontal and sagittal suture-derived mesenchymal cells (1 to 10 ng/ml). Quantitative real-time polymerase chain reaction was used to examine the effects of TGF-beta1 on gene expression. RESULTS: TGF-beta1 significantly decreased proliferation of both posterofrontal and sagittal suture-derived mesenchymal cells, by bromodeoxyuridine incorporation assays (n = 6). TGF-beta1 also inhibited osteogenesis in both suture-derived mesenchymal cells determined by alkaline phosphatase activity and mineralization (n = 3 for all assays). During chondrogenic differentiation, TGF-beta1 markedly increased expression of chondrocyte-specific gene markers in posterofrontal suture-derived mesenchymal cells (Sox9, Col II, Aggrecan, and Col X) (p <or= 0.05). In contrast, TGF-beta1 did not increase chondrocyte-specific gene expression in sagittal suture-derived mesenchymal cells (n = 3). CONCLUSIONS: Posterofrontal suture-derived mesenchymal cells retain significant capability for both osteogenic and chondrogenic differentiation in vitro. TGF-beta1 induces in vitro chondrogenesis in posterofrontal but not sagittal suture-derived mesenchymal cells. Future studies will focus on elucidating the mechanisms whereby TGF-beta signaling mediates chondrogenesis in posterofrontal suture-derived mesenchymal cells.
BACKGROUND: Evidence from animal studies has associated transforming growth factor (TGF)-beta signaling with both normal and premature cranial suture fusion. However, the mechanisms whereby this pleiotropic cytokine mediates suture fusion remain uncertain. The authors established cultures of suture-derived mesenchymal cells from normally fusing (posterofrontal) and patent (sagittal) sutures and examined the in vitro effects of TGF-beta1 on these distinct cell populations. METHODS: Skulls were harvested from 80 5-day-old mice. Posterofrontal and sagittal sutures were dissected, and cultures of suture-derived mesenchymal cells were established. The mitogenic, osteogenic, and chondrogenic effects of recombinant TGF-beta1 were then assessed on posterofrontal and sagittal suture-derived mesenchymal cells (1 to 10 ng/ml). Quantitative real-time polymerase chain reaction was used to examine the effects of TGF-beta1 on gene expression. RESULTS:TGF-beta1 significantly decreased proliferation of both posterofrontal and sagittal suture-derived mesenchymal cells, by bromodeoxyuridine incorporation assays (n = 6). TGF-beta1 also inhibited osteogenesis in both suture-derived mesenchymal cells determined by alkaline phosphatase activity and mineralization (n = 3 for all assays). During chondrogenic differentiation, TGF-beta1 markedly increased expression of chondrocyte-specific gene markers in posterofrontal suture-derived mesenchymal cells (Sox9, Col II, Aggrecan, and Col X) (p <or= 0.05). In contrast, TGF-beta1 did not increase chondrocyte-specific gene expression in sagittal suture-derived mesenchymal cells (n = 3). CONCLUSIONS: Posterofrontal suture-derived mesenchymal cells retain significant capability for both osteogenic and chondrogenic differentiation in vitro. TGF-beta1 induces in vitro chondrogenesis in posterofrontal but not sagittal suture-derived mesenchymal cells. Future studies will focus on elucidating the mechanisms whereby TGF-beta signaling mediates chondrogenesis in posterofrontal suture-derived mesenchymal cells.
Authors: Aaron W James; Benjamin Levi; Emily R Nelson; Michelle Peng; George W Commons; Min Lee; Benjamin Wu; Michael T Longaker Journal: Stem Cells Dev Date: 2010-10-17 Impact factor: 3.272
Authors: Jonathan R Peterson; Oluwatobi N Eboda; R Cameron Brownley; Katherine E Cilwa; Lauren E Pratt; Sara De La Rosa; Shailesh Agarwal; Steven R Buchman; Paul S Cederna; Michael D Morris; Stewart C Wang; Benjamin Levi Journal: Stem Cells Dev Date: 2015-01-15 Impact factor: 3.272
Authors: Aaron W James; Benjamin Levi; George W Commons; Jason Glotzbach; Michael T Longaker Journal: Plast Reconstr Surg Date: 2010-09 Impact factor: 4.730
Authors: Jonathan R Peterson; Oluwatobi Eboda; Shailesh Agarwal; Kavitha Ranganathan; Steven R Buchman; Min Lee; Stewart C Wang; Yuji Mishina; Benjamin Levi Journal: Stem Cells Transl Med Date: 2014-09-17 Impact factor: 6.940
Authors: Benjamin Levi; Aaron W James; Derrick C Wan; Jason P Glotzbach; George W Commons; Michael T Longaker Journal: Plast Reconstr Surg Date: 2010-07 Impact factor: 4.730
Authors: Benjamin Levi; Aaron W James; Emily R Nelson; Dean Vistnes; Benjamin Wu; Min Lee; Ankur Gupta; Michael T Longaker Journal: PLoS One Date: 2010-06-17 Impact factor: 3.240
Authors: Aaron W James; Alexander A Theologis; Samantha A Brugmann; Yue Xu; Antoine L Carre; Philipp Leucht; Katherine Hamilton; Kenneth S Korach; Michael T Longaker Journal: PLoS One Date: 2009-09-22 Impact factor: 3.240